Search

Financial results - STRATEGIKON PHARMA, INC. CALIFORNIA - SUCURSALA BUCURESTI

0.00
Financial Summary - Strategikon Pharma, Inc. California - Sucursala Bu
Unique identification code: 42706380
Registration number: J40/7219/2020
Nace: 6210
Sales - Ron
679.180
Net Profit - Ron
16.585
Employees
14
Open Account
Company Strategikon Pharma, Inc. California - Sucursala Bu with Fiscal Code 42706380 recorded a turnover of 2024 of 679.180, with a net profit of 16.585 and having an average number of employees of 14. The company operates in the field of Activităţi de realizare a soft-ului la comandă (software orientat client) having the NACE code 6210.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Strategikon Pharma, Inc. California - Sucursala Bu

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 0 256.400 367.578 380.775 679.180
Total Income - EUR - - - - - 2.189 259.492 371.806 383.921 680.821
Total Expenses - EUR - - - - - 23.239 239.496 360.856 374.675 661.519
Gross Profit/Loss - EUR - - - - - -21.050 19.995 10.950 9.246 19.303
Net Profit/Loss - EUR - - - - - -21.050 19.646 8.389 6.845 16.585
Employees - - - - - 1 4 5 8 14
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 79.4%, from 380.775 euro in the year 2023, to 679.180 euro in 2024. The Net Profit increased by 9.778 euro, from 6.845 euro in 2023, to 16.585 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Strategikon Pharma, Inc. California - Sucursala Bu

Rating financiar

Financial Rating -
STRATEGIKON PHARMA, INC. CALIFORNIA...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Strategikon Pharma, Inc. California...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Strategikon Pharma, Inc. California...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Strategikon Pharma, Inc. California...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Strategikon Pharma, Inc. California - Sucursala Bu - CUI 42706380

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 0 0 2.866 2.226 9.114
Current Assets - - - - - 27.040 38.712 26.895 49.144 92.795
Inventories - - - - - 0 0 0 0 0
Receivables - - - - - 3.308 0 1.940 10.371 14.760
Cash - - - - - 23.733 38.712 24.955 38.773 78.035
Shareholders Funds - - - - - -21.050 -937 7.449 14.272 30.776
Social Capital - - - - - 0 0 0 0 0
Debts - - - - - 48.091 39.649 22.311 37.173 71.132
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6210 - 6210"
CAEN Financial Year 6201
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 92.795 euro in 2024 which includes Inventories of 0 euro, Receivables of 14.760 euro and cash availability of 78.035 euro.
The company's Equity was valued at 30.776 euro, while total Liabilities amounted to 71.132 euro. Equity increased by 16.585 euro, from 14.272 euro in 2023, to 30.776 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Strategikon Pharma, Inc. California - Sucursala Bu

Comments - Strategikon Pharma, Inc. California - Sucursala Bucuresti

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.